Transaction overview
Pavarini Components, an Italian company specializing in hydraulic terminal design and manufacturing for agricultural and industrial applications, acquired Eurosnodi e TRB on April 17, 2026. The deal involves a 100% stake acquisition, though the financial details of the transaction were not disclosed. Eurosnodi is renowned for its decades-long expertise in developing high-quality hydraulic components such as spherical joints and terminal blocks, while TRB contributes extensive production capabilities tailored to customer-specific design requirements.
Deal structure and financing
The acquisition did not specify any detailed financial terms or split between equity and debt. Buy-side advisor Unistudio Corporate Finance managed the transaction on behalf of Pavarini Components, though no lead banks were mentioned for providing debt financing. Eurosnodi's owners received guidance from KPMG along with legal support from Baldi Prati & Partners during the sale process. The exact nature of any lock-up agreements or IPO considerations for the target company post-acquisition remains undisclosed.
Strategic context
Pavarini Components sought to enhance its product offerings and manufacturing capabilities through this acquisition, aiming to solidify its position in the hydraulic components market by leveraging Eurosnodi's expertise in quality standards and TRB's precision production processes. The acquirer intends to capitalize on synergies to offer more comprehensive solutions along the entire value chain of hydraulic components. For Eurosnodi e TRB, the divestiture represents an opportunity for continuity and growth under Pavarini Components' leadership while ensuring their specialized competencies are better aligned with broader industrial trends.
Regulatory path
Given that both companies operate within Italy, the transaction would likely have been reviewed by the Italian Competition Authority (ICA). The specific timeline for regulatory review is not available; however, it is standard practice to submit necessary filings under EU merger control regulations if the deal meets the jurisdictional thresholds. No remedies were required or disclosed as part of this acquisition process.